Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Wenzler

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|August 19, 2024
Multicenter evaluation of activity of aztreonam in combination with avibactam, relebactam, and vaborbactam against metallo-β-lactamase-producing carbapenem-resistant gram-negative bacilliLili Tao, Ashley Dahlquist, Harley Harris, et al.
The Annals of Pharmacotherapy|February 19, 2021
The Impact of Body Weight and Renal Function on the Risk of Bleeding With Direct Oral Anticoagulants in Atrial FibrillationHannah Whittemore, Andrew K Posen, Erika L Hellenbart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2022
Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against EnterobacteralesPranita D Tamma, Patrick N A Harris, Amy J Mathers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2023
Deconstructing the 2023 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Pseudomonas aeruginosaPranita D Tamma, Patrick N A Harris, Amy J Mathers, et al.
International Journal of Antimicrobial Agents|July 13, 2023
Pharmacokinetics and dialytic clearance of baricitinib during in vivo continuous venovenous haemodialysis in a patient with COVID-19Mary E Palmer, Rachel M Belcher, Anastasia Engeleit, et al.
Antimicrobial Agents and Chemotherapy|April 19, 2017
Pharmacokinetics and Dialytic Clearance of Ceftazidime-Avibactam in a Critically Ill Patient on Continuous Venovenous HemofiltrationEric Wenzler, Kristen L Bunnell, Susan C Bleasdale, et al.
Diagnostic Microbiology and Infectious Disease|November 26, 2015
Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremiaEric Wenzler, Debra A Goff, Julie E Mangino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Reply to Dilworth et alEric Wenzler, Fei Wang, Debra A Goff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2017
An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus BacteremiaEric Wenzler, Fei Wang, Debra A Goff, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2020
A coup d'état by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapyJustin R Lenhard, Amisha P Rana, Eric Wenzler, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|August 19, 2024
Multicenter evaluation of activity of aztreonam in combination with avibactam, relebactam, and vaborbactam against metallo-β-lactamase-producing carbapenem-resistant gram-negative bacilliLili Tao, Ashley Dahlquist, Harley Harris, et al.
The Annals of Pharmacotherapy|February 19, 2021
The Impact of Body Weight and Renal Function on the Risk of Bleeding With Direct Oral Anticoagulants in Atrial FibrillationHannah Whittemore, Andrew K Posen, Erika L Hellenbart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2022
Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against EnterobacteralesPranita D Tamma, Patrick N A Harris, Amy J Mathers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2023
Deconstructing the 2023 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Pseudomonas aeruginosaPranita D Tamma, Patrick N A Harris, Amy J Mathers, et al.
International Journal of Antimicrobial Agents|July 13, 2023
Pharmacokinetics and dialytic clearance of baricitinib during in vivo continuous venovenous haemodialysis in a patient with COVID-19Mary E Palmer, Rachel M Belcher, Anastasia Engeleit, et al.
Antimicrobial Agents and Chemotherapy|April 19, 2017
Pharmacokinetics and Dialytic Clearance of Ceftazidime-Avibactam in a Critically Ill Patient on Continuous Venovenous HemofiltrationEric Wenzler, Kristen L Bunnell, Susan C Bleasdale, et al.
Diagnostic Microbiology and Infectious Disease|November 26, 2015
Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremiaEric Wenzler, Debra A Goff, Julie E Mangino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Reply to Dilworth et alEric Wenzler, Fei Wang, Debra A Goff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2017
An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus BacteremiaEric Wenzler, Fei Wang, Debra A Goff, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2020
A coup d'état by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapyJustin R Lenhard, Amisha P Rana, Eric Wenzler, et al.
Pageof 8